English court grants Warner’s appeal in Lyrica second medical use case

01-06-2015

English court grants Warner’s appeal in Lyrica second medical use case

pxl.store / Shutterstock.com (The Royal Courts of Justice, where the English High Court is based.)

The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica (pregabalin).


English Court of Appeal, Warner-Lambert, Actavis, Lyrica, second medical use patent, patent

LSIPR